57 related articles for article (PubMed ID: 38662757)
21. An angiogenesis-related three-long non-coding ribonucleic acid signature predicts the immune landscape and prognosis in hepatocellular carcinoma.
Wang W; Ye Y; Zhang X; Sun W; Bao L
Heliyon; 2023 Mar; 9(3):e13989. PubMed ID: 36873490
[TBL] [Abstract][Full Text] [Related]
22. PAD4 and Its Inhibitors in Cancer Progression and Prognosis.
Zhu D; Lu Y; Wang Y; Wang Y
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365233
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms and therapeutic target of NETosis in diseases.
Huang J; Hong W; Wan M; Zheng L
MedComm (2020); 2022 Sep; 3(3):e162. PubMed ID: 36000086
[TBL] [Abstract][Full Text] [Related]
24. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma.
Donne R; Lujambio A
Hepatology; 2023 May; 77(5):1773-1796. PubMed ID: 35989535
[TBL] [Abstract][Full Text] [Related]
25. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
[No Abstract] [Full Text] [Related]
26. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
[TBL] [Abstract][Full Text] [Related]
27. Advances in the surgical treatment of liver cancer.
Maki H; Hasegawa K
Biosci Trends; 2022 Jul; 16(3):178-188. PubMed ID: 35732434
[TBL] [Abstract][Full Text] [Related]
28. Neutrophils as potential therapeutic targets in hepatocellular carcinoma.
Geh D; Leslie J; Rumney R; Reeves HL; Bird TG; Mann DA
Nat Rev Gastroenterol Hepatol; 2022 Apr; 19(4):257-273. PubMed ID: 35022608
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapies for hepatocellular carcinoma.
Llovet JM; Castet F; Heikenwalder M; Maini MK; Mazzaferro V; Pinato DJ; Pikarsky E; Zhu AX; Finn RS
Nat Rev Clin Oncol; 2022 Mar; 19(3):151-172. PubMed ID: 34764464
[TBL] [Abstract][Full Text] [Related]
30. Neutrophils in cancer carcinogenesis and metastasis.
Xiong S; Dong L; Cheng L
J Hematol Oncol; 2021 Oct; 14(1):173. PubMed ID: 34674757
[TBL] [Abstract][Full Text] [Related]
31. EGFR activation limits the response of liver cancer to lenvatinib.
Jin H; Shi Y; Lv Y; Yuan S; Ramirez CFA; Lieftink C; Wang L; Wang S; Wang C; Dias MH; Jochems F; Yang Y; Bosma A; Hijmans EM; de Groot MHP; Vegna S; Cui D; Zhou Y; Ling J; Wang H; Guo Y; Zheng X; Isima N; Wu H; Sun C; Beijersbergen RL; Akkari L; Zhou W; Zhai B; Qin W; Bernards R
Nature; 2021 Jul; 595(7869):730-734. PubMed ID: 34290403
[TBL] [Abstract][Full Text] [Related]
32. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
33. Neutrophils in cancer: heterogeneous and multifaceted.
Hedrick CC; Malanchi I
Nat Rev Immunol; 2022 Mar; 22(3):173-187. PubMed ID: 34230649
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma.
Guo C; Zhou S; Yi W; Yang P; Li O; Liu J; Peng C
Exp Mol Pathol; 2021 Jun; 120():104638. PubMed ID: 33878313
[TBL] [Abstract][Full Text] [Related]
35. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.
Liu D; Song T
Biosci Trends; 2021 Jul; 15(3):142-147. PubMed ID: 33716267
[TBL] [Abstract][Full Text] [Related]
36. Systemic therapy of liver cancer.
Demir T; Lee SS; Kaseb AO
Adv Cancer Res; 2021; 149():257-294. PubMed ID: 33579425
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma.
Llovet JM; Kelley RK; Villanueva A; Singal AG; Pikarsky E; Roayaie S; Lencioni R; Koike K; Zucman-Rossi J; Finn RS
Nat Rev Dis Primers; 2021 Jan; 7(1):6. PubMed ID: 33479224
[TBL] [Abstract][Full Text] [Related]
38. LNCcation: lncRNA localization and function.
Bridges MC; Daulagala AC; Kourtidis A
J Cell Biol; 2021 Feb; 220(2):. PubMed ID: 33464299
[TBL] [Abstract][Full Text] [Related]
39. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Huang DQ; El-Serag HB; Loomba R
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658
[TBL] [Abstract][Full Text] [Related]
40. NETosis: Molecular Mechanisms, Role in Physiology and Pathology.
Vorobjeva NV; Chernyak BV
Biochemistry (Mosc); 2020 Oct; 85(10):1178-1190. PubMed ID: 33202203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
